Life Molecular Imaging – Website

Innovative PET imaging agents for earlier and improved diagnosis and better characterization of diseases

Search Icon

Search for:

Menu Toggle Icon

Skip to content

Home
About us
Molecular Imaging
- How It Works
- Value of Molecular Imaging
Research & Development
Products
News
- Current News

Author: lifemolecular

DuChemBio Co. Ltd. and Life Molecular Imaging SA sign a Manufacturing and Supply Agreement for Alzheimer’s Disease Diagnostic Radiopharmaceutical for The Philippines

11. Jul 201911. Jul 2019lifemolecular

Read more: NeuraCeq (florbetaben) will be soon available in The Philippines

Life Molecular Imaging and National Cyclotron and PET Centre, Chulabhorn Royal Academy, Thailand Announce a Collaboration for Brain PET Imaging with NeuraCeq and PI-2620

15. Jun 201915. Jun 2019lifemolecular

Read more: Brain imaging research study with amyloid and tau PET to investigate aging Thai individuals aiming for development of models for a healthier life in the Thai society

Life Molecular Imaging and Institut de Radiofarmàcia Aplicada de Barcelona (IRAB) Announce a Strategic Partnership for Production of NeuraCeq and PI-2620 in Barcelona

26. Apr 201926. Apr 2019lifemolecular

Read more: Improved supply capabilities of NeuraCeq in the Communities of Catalonia and Aragon through the collaboration with IRAB. Investigational tau imaging agent PI-2620 added to the imaging biomarker platform for research studies.

Life Molecular Imaging Applauds the Publication of the IDEAS Study Aim I Results

8. Apr 20198. Apr 2019lifemolecular

Read more: Publication of IDEAS study aim 1 results shows that Amyloid PET Imaging was associated with changes in clinical management for Medicare beneficiaries with MCI, dementia, cognitive impairment or Alzheimer’s Disease

Life Molecular Imaging Announces Presentation of New Clinical Data of the Next Generation Tau PET Tracer PI-2620 at the AD/PD 2019 Conference

27. Mar 201927. Mar 2019lifemolecular

Readmore: New clinical data of PI-2620 Tau-PET highlight the sensitive detection of Tau pathology in neurodegenerative diseases .

Life Molecular Imaging and XingImaging Announce PI-2620 Tau PET Tracer Production in Mainland China

26. Oct 201826. Oct 2018lifemolecular

Readmore: Life Molecular Imaging (LMI) and XingImaging announced that production of LMI’s 18F-labeled Tau PET imaging agent PI-2620 has commenced at XingImaging sites in China.

Life Molecular Imaging and SOFIE announce PI-2620 Tau PET Tracer Production in SOFIE Radiopharmacy Network

13. Sep 201813. Sep 2018lifemolecular

Readmore: PI-2620 Tau PET tracer production for clinical trial supply has commenced in SOFIE Radiopharmacy Network

Posts navigation

← Older posts

© Copyright 2018 Life Molecular Imaging

Imprint / Data protection

Life Molecular Imaging – Website

Data Protection & Cookies. Our site uses cookies.
Click here to learn more: Data protection

Post to

Cancel